Cite
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease
MLA
Daniel Bunout, et al. “A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease.” Journal of Renal Nutrition : The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation, vol. 31, no. 1, Nov. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....07323c54c508871ad3e6096dbabebb58&authtype=sso&custid=ns315887.
APA
Daniel Bunout, Gladys Barrera, Eduardo Lorca, & Sandra Hirsch. (2019). A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease. Journal of Renal Nutrition : The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation, 31(1).
Chicago
Daniel Bunout, Gladys Barrera, Eduardo Lorca, and Sandra Hirsch. 2019. “A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of an Omega-3 Fatty Acid Supplement in Patients With Predialysis Chronic Kidney Disease.” Journal of Renal Nutrition : The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation 31 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....07323c54c508871ad3e6096dbabebb58&authtype=sso&custid=ns315887.